Nascent Biotech, Inc. reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported net loss was USD 0.540224 million compared to USD 1.3 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0889 USD | 0.00% | -1.11% | -48.58% |
1st Jan change | Capi. | |
---|---|---|
-48.58% | 15.17M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- NBIO Stock
- News Nascent Biotech, Inc.
- Nascent Biotech, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023